Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    eye ENT and dental

    Laryngeal carcinoma

    Also known as: Laryngeal cancer, Cancer of the larynx, Laryngeal malignancy, Laryngeal squamous cell carcinoma

    Laryngeal carcinoma represents a malignancy originating in the larynx, predominantly presenting as squamous cell carcinoma. Diagnosis, staging, and primary management are overseen by oncology specialists, incorporating surgical resection, radiotherapy, and systemic therapies, all of which may impair airway patency, phonation, deglutition, and nutrition. Traditional Chinese Medicine (TCM) serves exclusively as an adjunctive modality for supportive symptom management and must not impede conventional oncological treatment or surveillance. The cited evidence contains no clinical trials evaluating acupuncture or Chinese herbal medicine for this condition. While a small non-randomised study suggests supervised remote deglutition rehabilitation may facilitate postoperative recovery, clinical certainty remains low. Molecular research and broad reviews of fungi do not establish clinical patient benefits, and unrelated media studies regarding spinal stenosis offer no evidence for laryngeal carcinoma management.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Strictly adhere to the deglutition and bolus consistency protocols prescribed by the speech pathologist; refrain from unverified exercises or unsanctioned fluid viscosities.
    • •Maintain adherence to dietitian-led nutritional plans or prescribed enteral nutrition, ensuring diligent monitoring of body mass and intake as directed by the clinical team.
    • •Utilise professional smoking cessation services and consult the oncology team regarding the cessation of alcohol consumption.
    • •Maintain prescribed stoma and oral hygiene protocols, attend all scheduled oncological surveillance, and balance periods of rest with appropriate physical activity.

    Cautions & Contraindications

    See sources
    • •Do not give oral herbs, water or food against nil-by-mouth orders or prescribed texture restrictions; route and swallowing safety require treating-team approval. Source [1] supports the relevance of supervised postoperative swallowing care, not herb safety.[]
    • •Do not needle tumour tissue, the anterior neck, a stoma, surgical flaps, irradiated damaged skin or feeding-device sites. Obtain oncology clearance where cytopenias, infection or anticoagulation increase risk. These are general procedural precautions, not findings tested in [1].[]
    • •Do not use the Boletus review or the miRNA/GLI1/PTCH1 laboratory study to justify anticancer herbs, treatment substitution or claims of tumour response; neither establishes clinical benefit from the interventions in this guide.[,]

    When to reassess or seek care again

    See sources

    Review supportive care after 1–2 weeks, recording symptom ratings from 0–10, oral intake, weight trend, sleep and adverse effects. Coordinate swallowing outcomes with the speech pathologist rather than conducting independent oral trials. Source [1] reported changes at weeks 2 and 4 in a small non-randomised study; these are not guaranteed recovery milestones. Refer immediately for deterioration, aspiration concerns or dehydration; stop ineffective adjuncts and reconsider the plan if no meaningful benefit occurs within 2–4 weeks. Continue oncology surveillance regardless of symptom improvement.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Journal of telemedicine and telecare · 2026
    2. Medicine · 2026
    3. Frontiers in pharmacology · 2026
    4. Brazilian journal of otorhinolaryngology · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.